Here, we describe a novel mechanism of kidney-gut-pancreas crosstalk, wherein kidney-derived lysophosphatidic acid (LPA) decreases glucagon-like peptide 1 (GLP-1) levels to impair glucose-stimulated insulin secretion (GSIS), triggering glucose intolerance. The gene discussed is GLP1R; the disease is Glucose intolerance.